Buyback Spend for Pfizer (PFE)
Buyback Spend for Pfizer (PFE): headline value $0. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
PFE
Currently viewingBuyback SpendSwitch metric
Latest period
$0
YoY change
N/A
5Y CAGR
N/A
Peak year (2013)
$16.29B
Latest annual
$0
Buyback Spend history chart for Pfizer (PFE) from 1989 to 2025
Buyback Spend history table for Pfizer (PFE) from 1989 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $0 | — | ||
| 2024 | $0 | — | ||
| 2023 | $0 | -100.0% | ||
| 2022 | $2.00B | — | ||
| 2021 | $0 | — | ||
| 2020 | $0 | -100.0% | ||
| 2019 | $8.87B | -27.3% | ||
| 2018 | $12.20B | +144.0% | ||
| 2017 | $5.00B | 0.0% | ||
| 2016 | $5.00B | -18.8% | ||
| 2015 | $6.16B | +23.2% | ||
| 2014 | $5.00B | -69.3% | ||
| 2013 | $16.29B | +98.0% | ||
| 2012 | $8.23B | -8.6% | ||
| 2011 | $9.00B | +800.0% | ||
| 2010 | $1.00B | — | ||
| 2009 | $0 | -100.0% | ||
| 2008 | $500.00M | -95.0% | ||
| 2007 | $9.99B | +43.2% | ||
| 2006 | $6.98B | +83.8% | ||
| 2005 | $3.80B | -43.0% | ||
| 2004 | $6.66B | -48.9% | ||
| 2003 | $13.04B | +160.9% | ||
| 2002 | $5.00B | +36.3% | ||
| 2001 | $3.67B | +264.7% | ||
| 2000 | $1.00B | -60.5% | ||
| 1999 | $2.54B | +16.8% | ||
| 1998 | $2.18B | +271.5% | ||
| 1997 | $586.00M | +2070.4% | ||
| 1996 | $27.00M | -75.1% | ||
| 1995 | $108.50M | -78.8% | ||
| 1994 | $511.20M | -49.9% | ||
| 1993 | $1.02B | +53.3% | ||
| 1992 | $665.10M | +43.4% | ||
| 1991 | $463.90M | +250.9% | ||
| 1990 | $132.20M | -14.5% | ||
| 1989 | $154.70M | — |
Buyback Spend values are taken from Pfizer's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Pfizer (PFE) buyback spend totalled $0.
Across 2015–2025 (10 years), Pfizer buyback spend produced a CAGR of -100.0% – with a net decline across the window.
Pfizer buyback spend peaked at $16.29B in 2013; the latest annual figure is $0 in 2025 (100.0% below peak).
The dataset's maximum buyback spend sits at $16.29B (2013); the minimum reading of $0 dates to 2009.
Pfizer (PFE) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $2.75B.
Pfizer Buyback Spend by Year
Pfizer Buyback Spend 2025: $0
Pfizer buyback spend in 2025 was $0.
Pfizer Buyback Spend 2024: $0
Pfizer buyback spend in 2024 was $0.
Pfizer Buyback Spend 2023: $0
Pfizer buyback spend in 2023 was $0, plunged 100.0% below 2022.
Pfizer Buyback Spend 2022: $2.00B
Pfizer buyback spend in 2022 was $2.00B.
Pfizer Buyback Spend 2021: $0
Pfizer buyback spend in 2021 was $0.
See more financial history for Pfizer (PFE).
Sector peers — Buyback Spend
Companies in the same sector as Pfizer, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Pfizer's buyback spend?
Latest reported buyback spend for Pfizer (PFE) is $0 (period ending December 31, 2025).
What is the long-term growth rate of Pfizer buyback spend?
Pfizer (PFE) buyback spend compound annual growth rate is -100.0% over the most recent 10 years available.
When did Pfizer buyback spend hit its highest annual value?
Pfizer buyback spend reached its highest annual value of $16.29B in 2013.
What was Pfizer buyback spend in 2024?
Pfizer (PFE) buyback spend in 2024 was $0.
What was Pfizer buyback spend in 2025?
Pfizer (PFE) buyback spend in 2025 was $0.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
PFE Overview
Company profile, financial tools, and key metrics
PFE Revenue Counter
Earns $1,984 every second. See per minute, hour, and day.
PFE Earnings Counter
Earns $246.39 per second net profit. See per minute, hour, and day.
PFE Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
PFE What If Invested
What if you had invested $1,000? See historical returns from any date.
PFE How It Makes Money
Discover visual breakdown of $62.58B in revenue — where it comes from and where it goes.
PFE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PFE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PFE Daily Price Character
Steady · 46.3% historical win rate (green days). Streaks & record days.
PFE Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
PFE Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
PFE Dividend Profile
Yield: 6.55%. Safety: 3/8. See full history.
PFE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
PFE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.